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Abstract
Idiopathic generalized epilepsy (IGE) syndromes represent about 30% of all epilepsies. They have strong, but elusive,
genetic components and sex-specific seizure expression. Multiple linkage and population association studies have
connected the bromodomain-containing gene BRD2 to forms of IGE. In mice, a null mutation at the homologous Brd2 locus
results in embryonic lethality while heterozygous Brd2+/2 mice are viable and overtly normal. However, using the flurothyl
model, we now show, that compared to the Brd2+/+ littermates, Brd2+/2 males have a decreased clonic, and females a
decreased tonic-clonic, seizure threshold. Additionally, long-term EEG/video recordings captured spontaneous seizures in
three out of five recorded Brd2+/2 female mice. Anatomical analysis of specific regions of the brain further revealed
significant differences in Brd2+/2 vs +/+ mice. Specifically, there were decreases in the numbers of GABAergic (parvalbumin-
or GAD67-immunopositive) neurons along the basal ganglia pathway, i.e., in the neocortex and striatum of Brd2+/2 mice,
compared to Brd2+/+ mice. There were also fewer GABAergic neurons in the substantia nigra reticulata (SNR), yet there was
a minor, possibly compensatory increase in the GABA producing enzyme GAD67 in these SNR cells. Further, GAD67
expression in the superior colliculus and ventral medial thalamic nucleus, the main SNR outputs, was significantly decreased
in Brd2+/2 mice, further supporting GABA downregulation. Our data show that the non-channel-encoding,
developmentally critical Brd2 gene is associated with i) sex-specific increases in seizure susceptibility, ii) the development
of spontaneous seizures, and iii) seizure-related anatomical changes in the GABA system, supporting BRD2’s involvement in
human IGE.
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Introduction
Idiopathic generalized epilepsy (IGE) is mostly genetic in origin
[1] and represents about 30% of all epilepsies [2]. IGE comprises
several sub-syndromes including Juvenile Myoclonic Epilepsy
(JME) and Juvenile Absence Epilepsy (JAE) [3]. Although some
channel genes have been shown to cause some rare forms of
epilepsy [4], none have yet been proven to play a major role in the
far more common IGEs. Few IGE genes have been identified, and
those mostly through linkage scans chosen through specific
phenotypes. Of those genes only BRD2, which is not a channel
gene, has been both linked and associated in multiple studies with
a particular IGE, JME [5,6,7,8,9,10,11,12]. The statistical and
population evidence supports BRD2 as strongly influencing
susceptibility to JME in particular and, potentially, a wider range
of IGE syndromes/seizures, including photosensitivity [13,14] and
epilepsy-related electroencephalography (EEG) traits [6,8].
Statistical evidence supporting BRD2 as the EJM1 locus
for JME
Several linkage and association studies support BRD2 as the
EJM1 locus. The 6p21 locus was the first identified locus for a
common epilepsy (JME) [6], a finding independently replicated [7]
and confirmed again by Sander et al. [15], and in an independent
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24data set by Greenberg et al. [10]. Durner et al. [8] demonstrated
that the same locus led to the generalized electroencephalogram
(EEG) abnormality seen in both JME cases and in family members
unaffected with epilepsy and Tauer et al.[14] found linkage of
6p21 to the phenotype of photosensitivity using EEG. Greenberg
et al. [10] further found evidence of an association to a
microsatellite marker in the BRD2 gene, subsequently substanti-
ated by Pal et al. [11]. Later, in a follow-up to the Tauer et al.
findings, Lorenz et al. [13] showed association of BRD2 alleles to
photosensitivity.
Cavalleri et al. [12] examined 5 different populations and
confirmed the association of JME to BRD2 in two of those
populations: British and Irish. Two other populations, Indian and
Australian, did not show association. This locus had previously
been shown only Caucasian populations [10,15], which was
substantiated when no association was found in the Indian
population. The ethnic makeup of the Australian population was
unknown. The fifth population, German, illustrates the problems
in replication in association studies because this same population
showed linkage and association of BRD2 to the EEG trait (see
above). Because the evidence supports a role for BRD2 in epilepsy-
related brain function, finding the biological basis for its influence
on seizure susceptibility and abnormal (epileptiform) EEG traits
will help elucidate the mechanisms underlying the etiology of the
IGEs.
One of the problems in drawing conclusions from association
studies, especially when comparing two or more populations, is
that the existence of multiple disease-related alleles can make
data interpretation difficult. Two reports illustrate the confound-
ing factors in association studies of JME and the related EEG
traits.
In one report, Layouni et al. [16] found an association of JME
with the TAP1 gene in Tunisians. However, the authors found no
TAP1 association in Caucasians. That BRD2 does not associate
with JME in some non-Caucasian populations has previously been
demonstrated [10,12,15,17]. Furthermore, given the close prox-
imity of TAP1 to BRD2, one could speculate that, in Tunisians, a
DNA variant in TAP1 affects expression of BRD2. Such ‘‘long
distance’’ interactions have been reported in the past (e.g., [18]).
Moreover, a Tap1 knockout mouse shows no effects on brain
development [19], in contrast to the profound effects on neural
development in Brd22/2 mouse embryos [20] and our
observations on Brd2+/2 mice in the present study.
In a second report, de Kovel et al. [21] used a Dutch sample of
IGE patients to test for association of three BRD2 SNPs with the
IGE phenotype and, in a smaller sample, the JME phenotype.
They found no evidence of association of the three SNPs with
those phenotypes. However, the SNPs used by de Kovel et al. were
those reported associated, not with IGE or JME, but with EEG
photosensitivity in a study by Lorenz et al. [13]. Pal [11] had tested
JME (but not IGE) and had included only two of the three SNPs
tested by de Kovel et al. One of those SNPs showed no association
with JME in the Pal et al. report and one showed marginal
association (although other SNPs and SNP haplotypes showed
strong association evidence). de Kovel et al. rightly conclude that
the data neither confirm nor refute the BRD2 association
evidence. While de Kovel et al. did not test association of these
SNPs with photosensitivity in that work, in a later report, de Kovel
et al. [22] found no association of selected SNPs in BRD2 with a
photosensitivity subtype using, among others, the SNPs identified
in the Lorenz et al. photosensitivity study. However, the de Kovel
et al. cases were a mixture of IGE subtypes, thus perhaps diluting
any specific BRD2-related effect. Indeed, several studies show that
the chromosome 6p21 locus does not predispose to non-JME IGEs
[9,23,24]. Mixtures of patients with different phenotypes would be
less likely to be revealing.
Thus, because of the problems in interpretation due to different
populations, differing phenotypes, and the number of possible
different disease-related variants, association studies can take one
only so far in the attempt to identify the disease locus, the
responsible allele(s), and a possible biological mechanism.
Eventually, statistical evidence must point the way to seeking
biological evidence. We now have molecular biological data
suggesting an epilepsy-related mechanism related to BRD2.
Although the data are preliminary, we have observed that the
ratio of normally-spliced to alternatively spliced (and non-
functional) BRD2 RNA is a function of the number of tandem
GT repeats in a microsatellite located in intron 2 of BRD2 [25]. If
the ratio is small enough, such a situation could mimic
haploinusfficiency. Thus, it is possible that several different alleles
(or GT repeat lenths) may predispose to the brain-related
phenomena that we report here and that associations may differ
greatly depending on the frequencies of those alleles in the
population.
BRD2 is a member of the ‘BET’ subfamily of genes carrying
bromodomain motifs [26] that includes the genes (mouse/human
designation) Brd2/BRD2, Brd3/BRD3, Brd4/BRD4, and Brdt/
BRDT. The zebrafish homologue of the Brd2/BRD2 gene is highly
expressed in the egg, early embryo, and developing nervous system
[27]. Various functions have been ascribed to the BRD2 protein,
including transactivation of promoters of several cell cycle
regulatory genes [28], binding to mitotic chromosomes[29], and
interaction with acetylated lysine-12 in histones [30] but its role in
basic cellular functions in vivo remains unknown.
We generated a null mutation of the murine Brd2 gene using a
gene-trap approach [20]. Heterozygous Brd2+/2 mice are viable
and overtly normal. In contrast, the Brd2-null mutation (Brd22/2)
is incompatible with life: Brd22/2 mice die by embryonic day 11
and exhibit abnormal brain structures [20]. These observations
suggest that Brd2 is essential for neural development, observa-
tions subsequently confirmed by others [31]. Heterozygous
Brd2+/2 mice are viable and overtly normal. Understanding
how Brd2 functions during neural development in the mouse
model will give us insight into basic mechanisms of IGE, and
JME in particular.
In the present study, we determined if the viable and overtly
healthy heterozygous Brd2+/2 mice have increased susceptibility
to flurothyl-induced seizures and if they develop spontaneous
seizures. We further examined whether alterations in seizure
susceptibility are associated with changes in GABAergic markers
in the basal ganglia pathway involving cortex, striatum, substantia
nigra pars reticulata (SNR), superior colliculus (SC), and ventral
medial thalamic nucleus (VM). These areas were chosen because
we found that the Brd2+/2 mice display increased susceptibility to
primarily generalized seizures, and GABAergic mechanisms in the
SNR and SC have significant roles in controlling those seizure
types [32,33,34,35,36,37]. Changes in GABAergic neuron number
within an endogenous seizure-controlling network could account
for, or contribute to, increased seizure sensitivity or development
of spontaneous seizures. Indeed, we here demonstrate that the
viable and overtly healthy heterozygous Brd2+/2 mice [20] not
only show increased seizure susceptibility but develop spontaneous
generalized seizures with corresponding EEGs abnormalities. We
further show that the likely mechanism for this susceptibility is a
decrease in GABAergic neurons in the basal ganglia pathway,
including in the SNR, a critical seizure-controlling site [33]. Our
results suggest that a mechanism underlying JME is, in part, an
impairment in GABAergic inhibition due to wide-spread,
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tory neurons.
Results
Seizure susceptibility
We first asked whether heterozygous Brd2+/2 knockout mice
show increased seizure susceptibility with the ‘‘threshold test’’
using flurothyl exposure by inhalation. Decreased thresholds for
flurothyl-induced tonic-clonic seizures were observed in Brd2+/2
vs. Brd2+/+ female, but not male, mice, while Brd2+/2 males
showed decreased thresholds for clonic seizure induction.
In females, the threshold for flurothyl-induced tonic-clonic
seizures was statistically significantly (21%) lower in Brd2 +/2
(n=12) compared to Brd2 +/+ mice (n=12; ANOVA
F(1,22)=8.229; *p=0.009; Figure 1A). The two covariates of age
(range 3.5-8.0 months) and vaginal impedance were not found to
be significant in any analysis and were removed from the analysis.
(The lack of estrous cycle effect on flurothyl seizures is consistent
with a previous report [38].) The threshold for clonic seizures in
females did not differ between the genotypes (ANOVA
F(1,24)=0.112; p.0.74), unlike male mice (see below). Some
female mice developed multiple clonic seizures, but there was no
difference between the Brd2+/- and Brd2+/+ mice in the number
of clonic seizures (Mann-Whitney U=67.5; tied p.0.35). The
threshold for twitches did not differ between Brd2+/2 and Brd2+/+
mice (ANOVA F(1,24)=0.076; p.0.78). The death rate was
identical at 41.7% in Brd2+/2 and Brd2+/+ mice (Fisher’s exact
test p.0.99).
In Brd2+/2 male mice (n=16), the clonic seizure threshold
was significantly decreased by 18% compared to the Brd2+/+
males (n=12; ANOVA F(1,26)=10.338; *p=0.004; Figure 1B).
Although some mice developed multiple clonic seizures, there was
no difference in the total number of clonic seizures between the
Brd2+/+ and Brd2+/2 mice (Mann-Whitney U=77.5; tied
p.0.24). There was no significant difference in the male mice
(Brd2+/2 vs. Brd2+/+) in the threshold for induction of twitches
(ANOVA F(1,20)=1.901; p.0.18) or tonic-clonic seizures
(ANOVA (F(1,24)=2.777; p.0.10). We always used one covariate
(age: 3.5–8.0 months) on top of the main factor (genotype) but
there was no effect of age on the threshold for flurothyl-induced
twitches, clonic or tonic-clonic seizures, and no interaction of age
with the main factor of genotype. Therefore, we removed age as a
covariate in all statistics. Finally, the death rate did not differ
between Brd2+/2 (64.3%) and Brd2+/+ mice (41.7%; Fisher’s
exact test p.0.43) male mice.
Spontaneous seizures
To determine whether Brd2 haploinsufficiency is associated with
spontaneous seizure development, Brd2+/2 mice (females, n=5)
were subjected to long-term EEG/videomonitoring using two
unipolar frontal and one bipolar occipital EEG channels and
infrared video (Figure 2A). Three mice showed spontaneous
seizure events, one of which showed interictal discharges
(Figure 2B), sometimes associated with a whole body twitch.
These interictal discharges developed into true spontaneous spike-
and-wave clonic seizures lasting approximately 30 seconds each
(Figure 2C). One Brd2 +/2 mouse had a total of three seizures of
similar duration with an in-between interval of approximately
2 hours. A second Brd2+/2 mouse had one brief clonic seizure
that was recorded. The third mouse experienced relatively
frequent episodes (0–19 per 24 hours) of behavioral arrest
associated with EEG spindles of sharp waves, similar to human
absence seizures (Figure 2D), and died in protracted clonic seizures
(status epilepticus; Figure 2E) within 6 weeks of monitoring.
Examination of GABAergic neurons
The decrease in the flurothyl-induced, primarily generalized
seizure threshold and the presence of spontaneous primary
generalized seizures in Brd2+/2 mice suggested that there might
be changes in the generalized seizure control system, which
includes the SNR [32], and significant GABA involvement. We
also examined other structures of this circuit [39]: primary motor
cortex, caudate-putamen (CPu)/globus pallidus (GP), superior
colliculus (SC), and ventral medial (VM) thalamic nucleus [40].
We always tested for sex differences, but in those analyses in which
no male vs. female differences were detected, male and female
data were combined.
In the SNR, parvalbumin (PVA) is almost completely co-
expressed with GABA [41], thus serving as a marker of
GABAergic neurons. Differences in the number of GABAergic
neurons, which could directly affect seizure susceptibility [33],
would thus be reflected in the numbers of PVA-expressing
neurons. We found highly statistically significant differences in
the numbers of GABAergic neurons in the SNR. Brd2+/2 mice of
either sex (n=8; no sex differences present) had 20% fewer PVA-
immunopositive cells in the SNR than did Brd2+/+ controls (n=8;
both sexes combined) (*p=0.0008; Figure 3B).
We further hypothesized that the decreased number of PVA-
immunopositive (i.e., GABAergic) neurons in the SNR of Brd2+/2
mice could lead to a compensatory GABA overproduction
correlated with an increased GAD67 (a GABA-synthesizing
enzyme) content in those remaining GABAergic neurons. Thus,
using densitometry [42], we examined the average GAD67 content
in individual SNR cell bodies. There was a small (9%) but
Figure 1. Susceptibility of Brd2 heterozygous KO mice (+/-) and
control littermates (+/+) to flurothyl-induced seizures. Seizure
threshold is depicted in ml of flurothyl necessary to induce specific
seizure type (Mean6S.E.M.). (A) In females, tonic-clonic seizures in
Brd2+/- mice had significantly lower threshold than in Brd2+/+
littermate controls. (B) In males, clonic seizures in Brd2+/2 mice had
significantly lower threshold than in Brd2+/+ littermate controls.
doi:10.1371/journal.pone.0023656.g001
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expression in the SNR cell bodies in Brd2+/2 mice (n=8) vs.
Brd2+/+ controls (n=7), indicating a possible compensatory
increase in GABA synthesis.
We next examined GAD67 concentration in fibers in the
intermediate gray matter layer of the SC. This structure contains
SNR output and also plays a role in generalized seizure control
[43]. It is important to note that the GAD67 concentration in
fibers in the SNR target areas (such as SC or VM) is the product
of the number of GAD67-positive SNR cells and their GAD67
content. We measured areas devoid of cell bodies to look for
differences in the levels of GAD67 in axons emerging from the
SNR GABAergic neurons. We found a small (10%) but
statistically significant decrease in GAD67 immunodensity in
Brd2+/2 mice (n=7) compared to Brd2+/+ mice (n=8;
*p=0.018; Figure 3C) that was also not sex-related. For an
internal control, we examined the deep gray matter layer of the
SC (with negligible SNR inputs) and found no difference in
Brd2+/2 vs. Brd2+/+ GAD67 immunodensity (Figure 3C). The
data suggested that the changes in the numbers of GABAergic
neurons (PVA-positive) and in the levels of GAD67 within those
GABAergic cells that are found are pathway-specific, possibly
limited to basal ganglia connections.
In the striatum, we determined relative numbers of both GAD-
67- and PVA-immunopositive neurons. In both parts of the
striatum, the caudate/putamen (CPu) and globus pallidus (GP),
we found highly statistically significant decreases in numbers of
GAD67-immunopositive neurons in Brd2+/2 mice (n=7). In the
CPu, there was a 67% decrease compared to Brd2+/+ mice
(n=7; p,0.0001; Figure 3D). In the GP, the decrease in
GAD67-immunopositive neurons in Brd2+/2 mice was 32%
(*p=0.0026; Figures 3D, E, F). Again, there were no sex-related
differences.
Although we noted above that there was a major effect of
genotype on GAD67-immunopositive neurons, we saw no effect of
Brd2 genotype on PVA-immunopositive neuron numbers in either
CPu or GP, suggesting a structure-specific expression of
GABAergic neurons in Brd2+/2 mice. However, two-way
ANOVA revealed a significant effect of sex alone, consistent with
previously reported prenatal findings [44]: males had, on average,
30% fewer PVA-immunopositive neurons compared to females
irrespective of genotype (*p=0.0017; Figure 3G). This was unlike
Figure 2. Combined EEG/videorecordings of spontaneous seizures in Brd2+/2 mice. (A) Scheme of head mounted electrodes with one
reference (REF) in the nasal bone, one common ground in the occipital area, and active electrodes in the left and right frontal area (LF, RF,
respectively) and in both occipital areas (BiO). (B) EEG recordings of interictal discharges (one indicated by an arrow) in a Brd2+/2 mouse associated
with myoclonic jerks (twitches of body musculature). (C) EEG recordings from the same mouse showing a long EEG seizure consisting of spike-and-
wave pattern. Onset of seizure is marked by an arrowhead. (D) EEG recordings of spindle-shaped sharp wave episodes associated with behavioral
freezing in another Brd2+/2 mouse. Onset of two spindles (about 3 s and 1 s long) is marked by arrowheads. (E) Frozen video frames (under infrared
lighting) showing onset of a violent clonic seizure (E1) in a Brd2+/2 mouse and the end of status epilepticus (after more than an hour of clonic
seizures) in the same mouse (E2).
doi:10.1371/journal.pone.0023656.g002
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dependent difference in PVA-positive neuron count.
We also compared the number of GAD67- and PVA-
immunopositive neurons in the primary motor cortex. As in
the CPu and GP, there was a statistically significant 23%
decrease in the number of GAD67-positive neurons in Brd2+/2
mice (n=7) vs. Brd2+/+ mice (n=6; *p=0.025; Figure 3H).
However, like the CPu and GP and unlike the SNR, there was
no difference in the number of PVA-immunopositive neurons in
the motor cortex. Unlike the CPu and GP results (above), there
was no effect of sex on the numbers of either neuronal subtype
(Figure 3H).
Finally, we determined GAD67 concentration in areas of fibers
devoid of cell bodies in the thalamic VM, another significant
GABAergic output of the SNR, involved in seizure control [40].
Similar to SC, we found a small (7%) but statistically significant
decrease in GAD67 immunodensity in Brd2+/2 mice (n=8)
compared to Brd2+/+ mice (n=8; *p=0.048; Figure 3I). There
was no effect of sex on the GAD67 concentration and no
interaction between the sex of the subjects and genotype.
Figure 3. Expression of GABAergic markers in the Brd2+/2 mice and Brd2+/+ littermate controls. (A) Simplified scheme of a direct basal
ganglia pathway, which includes primary motor cortex, caudate-putamen (CPu) and globus pallidus (GP), substantia nigra reticulata (SNR), and its
outputs the superior colicullus (SC) and ventral medial thalamic nucleus (VM). Dark arrows indicate glutamatergic outputs, while grey arrows mark
GABAergic projections [39]. (B) Number of PVA-immunopositive neurons and density of GAD67 staining per neurons in the SNR of Brd2+/2 mice (+/2)
versus Brd2+/+ littermate controls (+/+; expressed in % of control values; mean 6S.E.M.). While the number of PVA-positive neurons significantly
decreased, the GAD67 content within neurons slightly increased in the SNR of Brd2+/2 mice. (C) GAD67 content in the fibers of the intermediate gray
matter layer (inter) of the SC was decreased in Brd2+/2 mice vs. Brd2+/+ controls. However, the GAD67 content in the deep gray matter layer of the SC
(deep) was not different between Brd2+/2 mice and. Brd2+/+ controls. This finding is consistent with presence of GABAergic terminals originating from
the SNR in the intermediate, but not deep, gray matter layer of the SC. (D) Number of GAD67-immunopositive neurons in the CPu and GP was
profoundly decreased in both parts of the striatum in Brd2+/2 mice compared to Brd2+/+ littermates illustrated further in microphotographs of upper
outer quadrant of CPu in a Brd2+/+ (E) and Brd2+/2 mouse (F). (G) Sex-specific difference in the relative number of PVA-positive neurons in the CPu.
Males irrespective of genotype had about 30% fewer PVA neurons than females. There was no significant effect of genotype. (H) There was a significant
decrease in number of GAD67-, but not PVA-immunopositive neurons in the primary motor cortex in Brd2+/2 mice versus Brd2+/+ controls. (I) GAD67
content in the fibers of the ventral medial thalamic nucleus (VM) in the Brd2+/2 mice was significantly decreased compared to Brd2+/+ controls. (J)
Number of PVA-immunopositive neurons in the hilar area of the dentate gyrus in both dorsal and ventral hippocampi was unchanged as in Brd2+/2
mice compared to Brd2+/+ littermates.
doi:10.1371/journal.pone.0023656.g003
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generalized seizures [45], we hypothesized that there will be no
differences in GABA markers in this structure. The distribution of
GABA markers in the hippocampus could thus indicate whether
the GABA-related changes in Brd2+/2 mice represent a global
brain feature or are specific for the basal ganglia pathway. There
were no genotypic or sex-related differences in PVA-immunopo-
sitive neuron numbers between Brd2+/2 and Brd2+/+ mice in the
dentate gyrus in the ventral and dorsal parts of the hippocampus,
suggesting the effect of a Brd2 deficit was confined to only certain
pathways (Figure 3J).
Discussion
This is the first demonstration of a developmentally-related
mechanism for seizure susceptibility of common forms of epilepsy.
That mechanism involves a deficit of GABAergic neurons caused
by haplo-insufficiency of the mouse Brd2 gene. This significant
deficit of inhibitory GABAergic neurons was observed along the
basal ganglia seizure-controlling pathway, but not in regions of the
brain outside this pathway (i.e., deep layers of the superior
colliculus not connected to the SNR or hippocampal dentate
gyrus). This decrease in inhibitory neurons and their GABA-
synthesizing enzyme expression (GAD67) presages increased
seizure susceptibility and spontaneous seizure development.
Even though the effects of a BRD2 deficiency in humans are
likely to be more subtle than those arising from a complete
elimination of one of the BRD2 alleles (the situation in the Brd2+/2
mice), there are consistent imaging-related differences in JME
patients vs. normals [46,47,48,49]. That is, there are additional
human findings, besides the genetic data, that directly connects
human epilepsy to our finding of a reduction in GABAergic
neurons in Brd2+/2 mouse basal ganglia pathway. Decreased
volume in the basal ganglia was reported in human IGE [50,51]
and a decrease in caudate nucleus blood-oxygen-level-dependent
(BOLD) MRI signal has been observed in children with absence
epilepsy [52]. Also, after treatment of IGE patients with
lamotrigine, there is reduced glucose metabolism in basal ganglia
(including the substantia nigra), and in cerebral cortex and
thalamus, further suggesting association of basal ganglia pathway
with IGE syndromes in humans [53]. These findings correlate well
with our data in the Brd2+/2 mouse model.
Our data show that haploinsufficiency for the Brd2 gene in mice
is associated with decreased number of GABAergic neurons,
which may be important for control of seizure activity, especially
in critical brain structures [54,55,56]. These results strengthen the
hypothesis that aberrant expression of human BRD2 contributes to
JME susceptibility, and perhaps other epilepsy-related phenome-
na, in humans. That is, GABAergic system impairment in Brd2+/2
mice suggests that a developmentally-based deficit of GABAergic
neurons might be a mechanism underlying the etiology of IGE. In
this study, we focused our observations on the GABA system
because we found increased susceptibility to primarily generalized
seizures and generalized spontaneous seizures. In these seizure
syndromes, structures and pathways containing GABA are
considered as major contributors [33,56,57,58,59]. However, we
cannot exclude participation of enhanced activity of glutamatergic
excitatory system in our findings. Further, the sex-related
differences we observed in the mice with a Brd2 deficit correlate
well with the sex-specific expression of seizure susceptibility in
human JME [60].
Thus, regulatory genes such as the bromodomain-containing
BRD2 may be significantly involved in common IGE syndromes.
The recent report of a role for the gene encoding the transcription
factor ELP4 in the development of centrotemporal EEG spikes in
rolandic epilepsy [61] further suggests that the common genetic
epilepsies can be influenced by genes involved in the regulation of
gene expression in brain development. The basis for autosomal
dominant partial epilepsy with auditory features (ADPEAF), the
LGI1 gene, also appears to have a developmental origin [62].
These findings are important for widening our perspectives on
which kinds of genes are responsible for IGE syndromes in
particular and seizure disorders in general.
An additional contribution of this study is the focus on
somewhat neglected subcortical basal ganglia structures [36]
specifically with regard to IGE. This focus represents a diversion
from the common approach of concentrating on the hippocampus,
amygdala, thalamus, or cortex, with regard to seizure disorders,
and indicates that specific seizure disorders may involve specific
brain structures. This finding may significantly contribute to novel
therapies focused on those brain nuclei in patients with IGE.
In conclusion our data clearly indicate that Brd2 haploinsuffi-
ciency is associated with a deficit of GABAergic neurons and along
the basal ganglia path in structures critical for control of seizure
activity. This developmentally-related impairment of the GA-
BAergic system likely contributes to increased susceptibility to
provoked seizures and to the development of spontaneous seizures
in Brd2+/2 mice. BRD2 has been associated and linked to the
expression of JME in humans, this underlying susceptibility could,
when another insult occurs, either environmental or genetic, lead
to the expression of epilepsy.
Materials and Methods
Ethics Statement
All animal utilization was carried out in strict accordance with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocols were approved by the IACUC of the Columbia
University (breeding; protocol number: AAAA8870) and the
Albert Einstein College of Medicine (experiments; protocol
number: 20080914). All surgery was performed under ketamine/
xylazine anesthesia, and all efforts were made to minimize
suffering and the number of mice used while keeping the statistical
power.
Brd2+/2 mice (Mus musculus) and Brd2+/+ littermates (controls)
were generated by mating heterozygous Brd2+/2 females to
heterozygous Brd2+/2 males. The mice used in this study were at
the 7
th generation of backcrossing onto a C57Bl/6J background.
At this step of backcrossing, their genetic background would be
considered on average 99% C57Bl/6J (Mouse Nomenclature,
jaxmice.jax.org). The genotypes of the mice were assessed by PCR
using primers that spanned the gene-trap vector junction inserted
into the Brd2 gene [20].
Vapor inhalation of flurothyl [bis(2,2,2-trifluorethyl) ether; CAS
333-36-8], induces a sequence of seizure behaviors: myoclonic
twitches, clonic seizures of face and forelimb muscles with
preserved righting ability, and tonic-clonic seizures of all four
limbs with the loss of righting [63]. Mice in pairs (always Brd2+/2
and Brd2+/+) were exposed to flurothyl in an air-tight chamber.
Flurothyl was delivered at a constant 40 ml/min rate until the
tonic-clonic seizures developed. Seizure behavior was evaluated by
two independent observers blinded to the mouse genotype.
Latency to onset of twitches, clonic, and tonic-clonic seizures
were recorded. The amount of flurothyl delivered by the time of
seizure onset served as the measure of the seizure threshold value
[64]. Female estrous cycles were monitored as changes in vaginal
epithelium impedance using a vaginal impedance meter (Fine
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progesterone and estrogen levels may alter seizure susceptibility
[68].
Pinnacle Technology, Inc., three-channel EEG system with
time-locked infrared videorecording was used for long-term EEG/
videomonitoring. Mice were implanted with EEG electrodes
under ketamine/xylazine (70/7 mg/kg i.p.) anesthesia. We used
epidural silver ball electrodes, positioned bilaterally in frontal and
occipital cortex. A stainless steel screw in the nasal bone was the
reference electrode, and a similar screw above the cerebellum
served as ground. The mice were recorded for minimum of 5 days,
24 hours a day. The recordings were first pre-sorted using Sirenia
Seizure software and all seizure-suspect segments were visually
inspected including video.
To identify GABAergic neurons, 40 mm thick coronal hemi-
sections, were cut. Alternating sections were collected for
parvalbumin (PVA) and GAD67 immunostaining. PVA is a useful
marker of GABAergic neurons in the SNR or hippocampal hilus,
where it almost completely co-expresses with GABA [41].
However, in other brain structures PVA is expressed only in
small subpopulations of GABAergic neurons. GAD67 (isozyme of
glutamic acid decarboxylase, a GABA synthesizing enzyme) tags
almost entire population of GABAergic neurons and additionally,
GAD67’s expression (density measurement) within individual cells
may provide an estimate of GABA synthesis. The immunostaining
was performed in free-floating sections using an avidin-biotin
horseradish peroxidase method (Vectastain AB kit, Vector
Laboratories, Burlingame, CA) [69] with primary antibodies:
anti-parvalbumin (1:5000; Sigma, St. Louis, MO); anti-GAD67
(1:4000; Millipore, Temecula, CA). We were interested only in
differences in cell numbers between Brd2+/2 and Brd2+/+ mice;
therefore, we compared the relative number of immunopositive
cells in Brd2+/2 and Brd2+/+ mice. Section images were digitally
captured. Counts were performed in the direct basal gaglia
pathway (primary motor cortex, striatum, SNR) and in the hilus of
the dorsal and ventral hippocampus to determine site-specificity of
findings. For counting, a minimum of three corresponding sections
were selected in each structure of interest in both Brd2+/2 and
Brd2+/+ mice and all immunopositive neurons were counted.
Counts were averaged and the average used for statistical
evaluation.
We also compared relative densities of GAD67 expression in
Brd2+/2 and Brd2+/+ mice. To minimize variability between the
groups, tissue from a heterozygote and a wild type mouse were
processed together. We evaluated the density of GAD67
immunoexpression in the SNR cells (manually outlined somata)
and in the fibers of the superior colliculus (SC) or ventral medial
thalamic nucleus (VM) [40,42] under 4006 magnification using
computer-assisted image analysis (ImageJ, Wayne Rasband, NIH)
to quantify the relative amounts of protein [70]. In three
corresponding sections per subject, we averaged semiquantitative
densitometry measurements of three samples of areas (same area
rectangles randomly positioned over the section) containing fibers
or five randomly chosen immunopositive cell somata. In the SC,
we measured GAD67 expression in the intermediate (receiving
abundant SNR input connections) and deep (sparse SNR inputs)
gray matter layers [71]. Three areas devoid of cell bodies were
manually outlined across each layer. All densitometry measure-
ments were normalized using in relation to white matter
background (non-specific staining in the cerebral peduncle for
the SC or mamillothalamic tract for the VM) and averaged for
each subject before entering statistics.
Statistics. Seizure susceptibility was evaluated by sex. For
seizure threshold evaluation, multivariate ANOVA was used.
Genotype was the main factor (levels: Brd2+/+ or Brd2+/2). Age
was used as a covariate in males; in females, age and vaginal
impedance were the covariates. A lack of effect of a covariate, and
no interaction with the main effect, caused the covariate’s removal
from the analysis. The numbers of clonic seizures were compared
by non-parametric Mann-Whitney U test. Immunopositive cell
numbers were compared first using ANOVA with factors of
genotype and sex. If no main effect of sex was found, the factor of
sex was removed from analysis and the evaluation was run using
Student’s t-test. Densitometric expression of GAD67 was
evaluated similarly. Significance threshold was set at p,0.05
and adjusted for multiple comparisons. Graphs show means
6S.E.M.s.
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